|
Macedonian Journal
of
Medical Sciences
|
||||
|
|
||||
|
About MJMS |
Our policies |
MJMS Online |
For contributors |
Services |
|
Why publish in
MJMS? |
Editorial & publishing policies |
Online first |
Guidelines
[pdf] |
Transliteration |
|
Abstract [Full-Text PDF] [Macedonian Abstract] [OnlineFirst Full-Text PDF]
Macedonian Journal of Medical Sciences. 2010 Jun 15; 3(2):119-122. doi:10.3889/MJMS.1857-5773.2010.0096 Basic Science
Bgl II Polymorhism of the
a2b1
Integrin Gene in Macedonian Population Marica Pavkovic1, Aleksandar Petlichkovski2, Aleksandar Stojanovic1, Dejan Trajkov2, Mirko Spiroski2 1Department of Hematology, Faculty of Medicine, University "Ss Kiril and Metodij", Skopje, Republic of Macedonia; 2Institute for Immunobiology and Human Genetics, Faculty of Medicine, University "Ss Kiril and Metodij", Skopje, Republic of Macedonia
Background. Glycoprotein (GP) Ia/IIa or a2b1 integrin is a platelet receptor for collagen and it mediates platelet adhesion to vascular subendothelium and is involved in thromb formation. Genetic polymorphism of a2b1 known as Bgl II affects the density of platelet GP Ia/IIa receptor on the platelet surface. Recent studies had shown relationship between this polymorphism and the risk of myocardial infarction, stroke, as well as diabetic retinopathy. Aim. The aim of this study was to determine the frequency of this polymorphism in Macedonian healthy population. Materials and Methods. We genotyped 217 healthy Macedonian individuals using the PCR and RFLP (restriction fragment length polymorphism) method. Results. The allele frequencies in this study were 0.32 for Bgl II (+) allele and 0.67 for Bgl II (-). Distribution of Bgl II genotypes in Macedonian population was Bgl II (+/+) = 16/217 (7.3%), Bgl II (+/-) =107/217 (49.3%) and Bgl II (-/-) = 94/217 (43.3%). Conclusion. Our results showed a slightly lower proportion of the Bgl II (+) allele (0.32) in Macedonian population, but not significantly different from other Caucasian population.
Key words: Bgl II polymorphism; GP Ia/IIa; platelet collagen receptor; genotypization; RFLP. |
|
Publication of the MJMS is supported by the Macedonian Ministry of Education and Sciences. Publisher: Institute of Immunobiology and Human Genetics, Skopje, Republic of Macedonia. |
![]() |
||
![]() |
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics. |
||
|
MJMS Print (ISSN 1857-5749) is an international peer-reviewed, Open Access journal published four times per year. MJMS Online (ISSN 1857-5773) offers free access to all articles. |
|||
All
site content, except where otherwise noted, is licensed under a
Creative
Commons Attribution License.